ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Epigenomics AG

Epigenomics AG (ECX1)

0.00
0.00
( 0.00% )
Updated: -
Realtime Data

Epigenomics AG Financial Summary

The current ECX1 market cap is 0. The company's latest EPS is EUR and P/E is N/A.

Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 1.13M843k6.2M485k750k
Operating Income -15.1M-10.11M-4.16M-12.86M-8.07M
Net Income -17.02M-11.69M-2.43M-12.02M-4.46M
Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 13.99M6.8M24.66M15.85M12.85M
Total Liabilities 4.36M2.93M2.54M5.68M12.85M
Total Equity 9.63M3.86M22.12M10.17M0

Cash Flow

Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating -13.51M-9.57M-4.15M-12.02M-5.71M
Investing 47k3k961k-1.7M68k
Financing 7.12M2.98M21.62M-359k-57k
Market Cap 0
Price to Earnings Ratio N/A
Price to Sales Ratio 0
Price to Cash Ratio 0
Price to Book Ratio 0
Dividend Yield -

Share Statistics

Shares Outstanding 4.09M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Epigenomics AG
Address geneststra��e 5
berlin 10829
Website https://www.epigenomics.com
Industry pharmaceutical preparations (2834)